The deal consolidates the eyewear company’s push into the health technology industry ahead of the presentation of its third-quarter results on Thursday. Financial terms for the acquisition weren’t disclosed.
“In the past year alone, we’ve made several bold moves in med-tech, all with the goal of building the most comprehensive, digitally enabled patient journey,” EssilorLuxottica Chairman and Chief Executive Officer
Ikerian AG, the company that ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.